Gary Nachman
Stock Analyst at Canaccord Genuity
(2.21)
# 3,122
Out of 5,010 analysts
492
Total ratings
46.3%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Gary Nachman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Reiterated: Buy | $290 | $266.28 | +8.91% | 46 | Sep 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $85 | $45.57 | +86.53% | 39 | Sep 24, 2026 | |
| AMGN Amgen | Reiterated: Hold | $384 | $418.13 | -8.16% | 6 | Sep 23, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $238.28 | +25.90% | 53 | Aug 31, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $13 | $7.75 | +67.74% | 9 | Aug 12, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $62 | $49.13 | +26.20% | 15 | Aug 12, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Hold | $91 → $90 | $74.83 | +20.27% | 6 | Aug 10, 2026 | |
| ADMA ADMA Biologics | Reiterated: Buy | $18 | $10.12 | +77.87% | 9 | Aug 6, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $60 | $59.18 | +1.39% | 2 | Jul 30, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | n/a | $25.39 | - | 48 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16.98 | $11.65 | +45.75% | 7 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $2.53 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.00 | n/a | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $40 | $3.96 | n/a | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.75 | n/a | 18 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $16.95 | n/a | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 | $255.36 | n/a | 23 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $69.45 | n/a | 7 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $100 | $0.0001 | n/a | 8 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $9.60 | n/a | 22 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4 | $20.50 | n/a | 19 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $7.35 | n/a | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $78 | $29.50 | n/a | 5 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 | $18.27 | n/a | 17 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11.32 → $14.15 | $8.21 | n/a | 42 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $32 | $13.92 | n/a | 11 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $49.36 | n/a | 11 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $35 | $0.000001 | n/a | 10 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $5.31 | n/a | 6 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 | $1.24 | n/a | 3 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $12 | $14.39 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $27.39 | n/a | 14 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $3 | $0.0001 | n/a | 5 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $52.18 | n/a | 1 | Sep 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $91.62 | n/a | 3 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9.5 → $14 | $4.12 | n/a | 2 | Mar 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6.8 | $13.22 | n/a | 2 | Oct 9, 2013 |
AbbVie
Sep 29, 2026
Reiterated: Buy
Price Target: $290
Current: $266.28
Upside: +8.91%
Ionis Pharmaceuticals
Sep 24, 2026
Reiterated: Buy
Price Target: $85
Current: $45.57
Upside: +86.53%
Amgen
Sep 23, 2026
Reiterated: Hold
Price Target: $384
Current: $418.13
Upside: -8.16%
Jazz Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $300
Current: $238.28
Upside: +25.90%
Achieve Life Sciences
Aug 12, 2026
Reiterated: Buy
Price Target: $13
Current: $7.75
Upside: +67.74%
Scholar Rock Holding
Aug 12, 2026
Reiterated: Buy
Price Target: $62
Current: $49.13
Upside: +26.20%
ANI Pharmaceuticals
Aug 10, 2026
Reiterated: Hold
Price Target: $91 → $90
Current: $74.83
Upside: +20.27%
ADMA Biologics
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $10.12
Upside: +77.87%
Eton Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $60
Current: $59.18
Upside: +1.39%
Pacira BioSciences
Oct 6, 2025
Reiterated: Hold
Price Target: n/a
Current: $25.39
Upside: -
Oct 2, 2025
Reiterated: Buy
Price Target: $16.98
Current: $11.65
Upside: +45.75%
Aug 13, 2025
Reiterated: Buy
Price Target: $3 → $20
Current: $2.53
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $37 → $40
Current: $3.96
Upside: n/a
Jun 17, 2025
Reiterated: Buy
Price Target: $7
Current: $4.75
Upside: n/a
Feb 20, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $16.95
Upside: n/a
Jan 15, 2025
Reiterated: Buy
Price Target: $298
Current: $255.36
Upside: n/a
Aug 19, 2024
Reiterated: Buy
Price Target: $7 → $4
Current: $69.45
Upside: n/a
Mar 16, 2023
Rated: Buy
Price Target: $200 → $100
Current: $0.0001
Upside: n/a
Mar 8, 2023
Reiterated: Buy
Price Target: $5 → $4
Current: $9.60
Upside: n/a
Mar 2, 2023
Rated: Hold
Price Target: $4
Current: $20.50
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $35 → $30
Current: $7.35
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $83 → $78
Current: $29.50
Upside: n/a
Feb 27, 2023
Rated: Hold
Price Target: $14
Current: $18.27
Upside: n/a
Feb 24, 2023
Reiterated: Hold
Price Target: $11.32 → $14.15
Current: $8.21
Upside: n/a
Feb 22, 2023
Rated: Buy
Price Target: $40 → $32
Current: $13.92
Upside: n/a
Jan 9, 2023
Rated: Buy
Price Target: $3
Current: $49.36
Upside: n/a
Nov 10, 2022
Reiterated: Buy
Price Target: $60 → $35
Current: $0.000001
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $27 → $25
Current: $5.31
Upside: n/a
Aug 2, 2021
Reiterated: Buy
Price Target: $180
Current: $1.24
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $13 → $12
Current: $14.39
Upside: n/a
May 11, 2020
Reiterated: Hold
Price Target: $21
Current: $27.39
Upside: n/a
Sep 5, 2019
Reiterated: Buy
Price Target: $9 → $3
Current: $0.0001
Upside: n/a
Sep 14, 2017
Reiterated: Buy
Price Target: $80
Current: $52.18
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $138
Current: $91.62
Upside: n/a
Mar 21, 2016
Initiated Coverage: Hold
Price Target: $9.5 → $14
Current: $4.12
Upside: n/a
Oct 9, 2013
Reiterated: Hold
Price Target: $6.8
Current: $13.22
Upside: n/a